{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T19:34:38Z","timestamp":1767641678748,"version":"3.48.0"},"posted":{"date-parts":[[2025,10,29]]},"group-title":"In Review","reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,9,8]]},"abstract":"<title>Abstract<\/title>\n                <p>Viet Nam faces a significant burden of viral hepatitis-associated liver disease, but the contribution of HDV, the most severe form of viral hepatitis, remains underinvestigated. HDV is substantial in the Northern and Central regions, but has not been documented in the South of Viet Nam. To investigate HDV prevalence and its association with severe liver disease in Southern Viet Nam, we used the standardized assay (LIAISON\u00ae XL Anti-HDV) to detect HDV antibodies (anti-HDV) in 721 HBsAg positive individuals with hepatitis flare (n\u2009=\u2009158), liver cirrhosis (LC) (181), hepatocellular carcinoma (HCC) (207), chronic hepatitis B (CHB) (175). Unexpectedly, anti-HDV was rare and only detected in 11\/721 participants (1.5%), and not significantly different among groups: 2\/158 (1.3%) in flare, 4\/181 (2.2%) in LC, and 5\/207 (2.4%) in HCC, and 0\/175 (0%) in CHB. This suggests that HDV is not one of the major contributors to the high burden of liver disease in Southern Viet Nam. The discrepancy of HDV prevalence between Northern-Central and Southern regions suggests location-specific distribution of HDV, which in turn reflects differences in HDV transmission routes, study populations, and\/or study methodologies.  Our study underscores the need for tailored, regional screening strategies rather than a single national guideline for HDV infection.<\/p>","DOI":"10.21203\/rs.3.rs-7566353\/v1","type":"posted-content","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:54:47Z","timestamp":1761749687000},"source":"Crossref","is-referenced-by-count":0,"title":["Unexpectedly Low Prevalence of Hepatitis Delta Virus Infection in Southern Viet Nam"],"prefix":"10.21203","author":[{"given":"Thuy","family":"Nguyen","sequence":"first","affiliation":[{"name":"National Cancer Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Van Huy","family":"Vo","sequence":"additional","affiliation":[{"name":"University Medical Center HCMC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Le","sequence":"additional","affiliation":[{"name":"National Cancer Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An Bac","family":"Luong","sequence":"additional","affiliation":[{"name":"University of Medicine and Pharmacy at Ho Chi Minh City"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuong Dinh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"University Medical Center HCMC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phong Tien","family":"Quach","sequence":"additional","affiliation":[{"name":"University Medical Center HCMC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thuy Thi-Thanh","family":"Trinh","sequence":"additional","affiliation":[{"name":"University Medical Center HCMC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang The","family":"Phan","sequence":"additional","affiliation":[{"name":"University Medical Center HCMC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuan Ngoc","family":"Cao","sequence":"additional","affiliation":[{"name":"University Medical Center HCMC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thi Bich Chi","family":"Mai","sequence":"additional","affiliation":[{"name":"University Medical Center HCMC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vu Anh","family":"Hoang","sequence":"additional","affiliation":[{"name":"University of Medicine and Pharmacy at Ho Chi Minh City"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoang Huu","family":"Bui","sequence":"additional","affiliation":[{"name":"University Medical Center HCMC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Maldarelli","sequence":"additional","affiliation":[{"name":"National Cancer Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-8278(85)80766-2","article-title":"Delta hepatitis\u2013present status","volume":"1","author":"Rizzetto M","year":"1985","unstructured":"Rizzetto, M. & Verme, G. Delta hepatitis\u2013present status. J. Hepatol. 1, 187\u2013193 (1985).","journal-title":"J. Hepatol."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrgastro.2009.205","article-title":"Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead","volume":"7","author":"Wedemeyer H","year":"2010","unstructured":"Wedemeyer, H. & Manns, M. P. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat. Rev. Gastroenterol. Hepatol. 7, 31\u201340 (2010).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref3","unstructured":"World Health Organization. Switzerland (2019). Available at https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-d"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","article-title":"The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis","volume":"73","author":"Stockdale AJ","year":"2020","unstructured":"Stockdale, A. J. et al. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. J. Hepatol. 73, 523\u2013532 (2020).","journal-title":"J. Hepatol."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/gutjnl-2018-316601","article-title":"Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis","volume":"68","author":"Chen HY","year":"2019","unstructured":"Chen, H. Y. et al. Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis. Gut 68, 512\u2013521 (2019).","journal-title":"Gut"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3390\/v13050830","article-title":"Hepatitis D Virus and Hepatocellular Carcinoma","volume":"13","author":"Farci P","year":"2021","unstructured":"Farci, P., Niro, G. A., Zamboni, F. & Diaz, G. Hepatitis D Virus and Hepatocellular Carcinoma. Viruses 13, 830 (2021).","journal-title":"Viruses"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra2212151","article-title":"Hepatitis D Virus Infection","volume":"389","author":"Asselah T","year":"2023","unstructured":"Asselah, T. & Rizzetto, M. Hepatitis D Virus Infection. N Engl. J. Med. 389, 58\u201370 (2023).","journal-title":"N Engl. J. Med."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault NA","year":"2018","unstructured":"Terrault, N. A. et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 67, 1560\u20131599 (2018).","journal-title":"Hepatology"},{"key":"ref9","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol S0168-8278(25)00174\u20136. (2025). 10.1016\/j.jhep.2025.03.018"},{"key":"ref10","unstructured":"World Health Organization (WHO). Hepatitis data and statistics in the Western Pacific."},{"key":"ref11","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray F","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang JD","year":"2019","unstructured":"Yang, J. D. et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat. Rev. Gastroenterol. Hepatol. 16, 589\u2013604 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref13","first-page":"100468","article-title":"Seroprevalence of Hepatitis B, C and D in Vietnam: A systematic review and meta-analysis","volume":"24","author":"Flower B","year":"2022","unstructured":"Flower, B. et al. Seroprevalence of Hepatitis B, C and D in Vietnam: A systematic review and meta-analysis. Lancet Reg. Health West. Pac. 24, 100468 (2022).","journal-title":"Lancet Reg. Health West. Pac."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e39027","DOI":"10.1371\/journal.pone.0039027","article-title":"A multicentre molecular analysis of hepatitis B and blood-borne virus coinfections in Viet Nam","volume":"7","author":"Dunford L","year":"2012","unstructured":"Dunford, L. et al. A multicentre molecular analysis of hepatitis B and blood-borne virus coinfections in Viet Nam. PLoS One. 7, e39027 (2012).","journal-title":"PLoS One"},{"key":"ref15","unstructured":"International Agency for Research on Cancer, World Health Organization. Global Cancer Observatory, VIET NAM."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"18475","DOI":"10.1038\/s41598-024-69304-8","article-title":"Assessing the diagnostic accuracy of serological tests for hepatitis delta virus diagnosis: a systematic review and meta-analysis","volume":"14","author":"Akuffo GA","year":"2024","unstructured":"Akuffo, G. A. et al. Assessing the diagnostic accuracy of serological tests for hepatitis delta virus diagnosis: a systematic review and meta-analysis. Sci. Rep. 14, 18475 (2024).","journal-title":"Sci. Rep."},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/hep.28772","article-title":"First international external quality assessment for hepatitis delta virus RNA quantification in plasma","volume":"64","author":"Gal F","year":"2016","unstructured":"Le Gal, F., Brichler, S., Sahli, R., Chevret, S. & Gordien, E. First international external quality assessment for hepatitis delta virus RNA quantification in plasma. Hepatology 64, 1483\u20131494 (2016).","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"113715","DOI":"10.1016\/j.jviromet.2019.113715","article-title":"Impact of nucleic acid extraction platforms on hepatitis virus genome detection","volume":"273","author":"Pauly MD","year":"2019","unstructured":"Pauly, M. D., Kamili, S. & Hayden, T. M. Impact of nucleic acid extraction platforms on hepatitis virus genome detection. J. Virol. Methods. 273, 113715 (2019).","journal-title":"J. Virol. Methods"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e70036","DOI":"10.1111\/jvh.70036","article-title":"Droplet Digital PCR: A Powerful Tool for Accurate Quantification of Hepatitis D Virus RNA Levels and Verification of Detection Limits","volume":"32","author":"Sandmann L","year":"2025","unstructured":"Sandmann, L. et al. Droplet Digital PCR: A Powerful Tool for Accurate Quantification of Hepatitis D Virus RNA Levels and Verification of Detection Limits. J. Viral Hepat. 32, e70036 (2025).","journal-title":"J. Viral Hepat."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/HEP.0000000000000584","article-title":"HDV RNA assays: Performance characteristics, clinical utility, and challenges","volume":"81","author":"Wedemeyer H","year":"2025","unstructured":"Wedemeyer, H. et al. HDV RNA assays: Performance characteristics, clinical utility, and challenges. Hepatology 81, 637\u2013650 (2025).","journal-title":"Hepatology"},{"author":"LIAISON\u00ae","key":"ref21","unstructured":"LIAISON\u00ae XL MUREX Anti-HDV performances."},{"author":"RoboGene HDVRNA","key":"ref22","unstructured":"RoboGene, H. D. V. R. N. A. Quantification Kit 2.0 performances."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(82)90156-8","article-title":"Influence of delta infection on severity of hepatitis B","volume":"2","author":"Smedile A","year":"1982","unstructured":"Smedile, A. et al. Influence of delta infection on severity of hepatitis B. Lancet 2, 945\u2013947 (1982).","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s12879-017-2697-x","article-title":"Molecular characterization of hepatitis B virus in Vietnam","volume":"17","author":"Bui TTT","year":"2017","unstructured":"Bui, T. T. T. et al. Molecular characterization of hepatitis B virus in Vietnam. BMC Infect. Dis. 17, 601 (2017).","journal-title":"BMC Infect. Dis."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12072-009-9141-2","article-title":"Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B","volume":"3","author":"Nguyen LH","year":"2009","unstructured":"Nguyen, L. H. et al. Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B. Hepatol. Int. 3, 461\u2013467 (2009).","journal-title":"Hepatol. Int."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/v13020346","article-title":"Predominance of HBV Genotype B and HDV Genotype 1 in Vietnamese Patients with Chronic Hepatitis","volume":"13","author":"Hoan NX","year":"2021","unstructured":"Hoan, N. X. et al. Predominance of HBV Genotype B and HDV Genotype 1 in Vietnamese Patients with Chronic Hepatitis. Viruses 13, 346 (2021).","journal-title":"Viruses"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/1471-2407-11-458","article-title":"Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients","volume":"11","author":"Tatsukawa M","year":"2011","unstructured":"Tatsukawa, M. et al. Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients. BMC Cancer. 11, 458 (2011).","journal-title":"BMC Cancer"},{"key":"ref28","first-page":"100620","article-title":"Establishing baseline framework for hepatitis B virus micro-elimination in Ho Chi Minh City, Vietnam - A community-based seroprevalence study","volume":"30","author":"Pham TND","year":"2023","unstructured":"Pham, T. N. D. et al. Establishing baseline framework for hepatitis B virus micro-elimination in Ho Chi Minh City, Vietnam - A community-based seroprevalence study. Lancet Reg. Health West. Pac. 30, 100620 (2023).","journal-title":"Lancet Reg. Health West. Pac."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e28634","DOI":"10.1002\/jmv.28634","article-title":"Improved hepatitis delta virus genome characterization by single molecule full-length genome sequencing combined with VIRiONT pipeline","volume":"95","author":"Charre C","year":"2023","unstructured":"Charre, C. et al. Improved hepatitis delta virus genome characterization by single molecule full-length genome sequencing combined with VIRiONT pipeline. J. Med. Virol. 95, e28634 (2023).","journal-title":"J. Med. Virol."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1099\/vir.0.026666-0","article-title":"A complex hepatitis B virus (X\/C) recombinant is common in Long An county, Guangxi and may have originated in southern China","volume":"92","author":"Fang ZL","year":"2011","unstructured":"Fang, Z. L. et al. A complex hepatitis B virus (X\/C) recombinant is common in Long An county, Guangxi and may have originated in southern China. J. Gen. Virol. 92, 402\u2013411 (2011).","journal-title":"J. Gen. Virol."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e9490","DOI":"10.1371\/journal.pone.0009490","article-title":"FastTree 2\u2013approximately maximum-likelihood trees for large alignments","volume":"5","author":"Price MN","year":"2010","unstructured":"Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree 2\u2013approximately maximum-likelihood trees for large alignments. PLoS One. 5, e9490 (2010).","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1471-2105-14-317","article-title":"Automated analysis of phylogenetic clusters","volume":"14","author":"Ragonnet-Cronin M","year":"2013","unstructured":"Ragonnet-Cronin, M. et al. Automated analysis of phylogenetic clusters. BMC Bioinform. 14, 317 (2013).","journal-title":"BMC Bioinform."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7566353\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7566353\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T16:10:04Z","timestamp":1767629404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7566353\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":32,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-7566353\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41598-025-33268-0","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,10,29]]},"subtype":"preprint"}}